Joint Stock Co Pharmstandard Public, 10% Owner at ARGOS THERAPEUTICS INC (ARGS), bought 5,983,549 shares at $8.00 ($10.2M) on 2014-02-12, disclosed to the SEC on 2014-02-12.
Open-market purchase of $10.2M ARGS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,708,549 | $0 | 0.0% |
| 2 | $8.00 | 1,275,000 | $10.2M | 100.0% |
| Total | $1.70 avg | 5,983,549 | $10.2M | 100% |
| Filing → |
| ARGS | BUY | 2016-09-21 | $420K | — | Filing → |
| ARGS | BUY | 2016-09-20 | $501K | — | Filing → |
| ARGS | BUY | 2016-08-25 | $305K | — | Filing → |